Prospera Financial Services’s TG Therapeutics TGTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$698K	Sell	20,998 -5,495	-21%	-$164K	0.01%	871
2025 Q4	$790K	Sell	26,493 -4,230	-14%	-$138K	0.01%	770
2025 Q3	$1.11M	Buy	30,723 +648	+2%	+$21.3K	0.02%	643
2025 Q2	$1.08M	Buy	30,075 +1,112	+4%	+$41.4K	0.02%	626
2025 Q1	$1.14M	Sell	28,963 -5,550	-16%	-$187K	0.03%	528
2024 Q4	$1.04M	Sell	34,513 -1,200	-3%	-$34.4K	0.02%	531
2024 Q3	$835K	Sell	35,713 -2,712	-7%	-$59.2K	0.02%	551
2024 Q2	$684K	Sell	38,425 -665	-2%	-$10.6K	0.02%	604
2024 Q1	$595K	Buy	39,090 +750	+2%	+$11.9K	0.02%	649
2023 Q4	$655K	Buy	38,340 +6,865	+22%	+$79.8K	0.02%	574
2023 Q3	$263K	Buy	31,475 +200	+0.6%	+$2.79K	0.01%	852
2023 Q2	$777K	Sell	31,275 -6,000	-16%	-$155K	0.03%	485
2023 Q1	$561K	Buy	37,275 +18,625	+100%	+$283K	0.02%	577
2022 Q4	$221K	Buy	+18,650	New	+$135K	0.01%	816
2022 Q3	–	Sell	-6,700	Closed	-$28K	–	1518
2022 Q2	$28K	Sell	6,700 -620	-8%	-$3.87K	﹤0.01%	1142
2022 Q1	$70K	Buy	+7,320	New	+$84.7K	﹤0.01%	1237